Jonathan Rende, Chief Research & Development Officer at CASTLIGHT HEALTH, INC. (CSLT), sold 41,832 shares at $3.56 ($153K) on 2017-02-16, disclosed to the SEC on 2017-02-17.
Open-market sale of $153k CSLT by Chief Research & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 8,290 | $29K | 19.3% |
| 2 | $3.56 | 8,290 | $30K | 19.3% |
| 3 | $3.71 | 12,626 | $47K | 30.7% |
| 4 | $3.71 | 12,626 | $47K | 30.7% |
| Total | $3.65 avg | 41,832 | $153K | 100% |
| Filing → |
| CSLT | SELL | 2016-05-17 | $205K | — | Filing → |